Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Anesthesia and Analgesia

Volume  7, Issue 5, September – October 2020, Pages 1187-1191
 

Original Article

Effectiveness of 5% Lidocaine Patch in Post Mastectomy Cancer Pain – A Randomized Controlled Trial

Sushree Das1, Nupur Moda2, Madhusmita Patro3

1-3Assistant Professor, Department of Anesthesiology and Pain Medicine, Institute of Medical Sciences and SUM Hospital, Bhubaneswar, Odisha 751003, India

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.7520.45

Abstract

Background: The control of cancer pain still is a significant problem in patients undergoing major oncological surgical procedures. The use of high dose opioids has resulted in multiple side effects. The present study was carried out to analyze the effectiveness of a 5% lidocaine patch in patients with cancer pain undergoing mastectomy. Methods: This was a prospective randomized control trial. Sixty patients were included in the study. Group A patients have 5% lidocaine patch applied, and in Group B, a placebo patch was used. Demographic profile, the severity of pain score, and opioid requirement, at the beginning and conclusion of the treatment, patients’ impression, drug-related side effects all were noted. Results: 60 patients took part in the study, with fourteen days mean follow up. The Mean Verbal Numerical Scale (VNS) score was 3.5 in Group A and 6.76 in Group B at Day 1(P=0.00), and VNS Score was 4.06 in Group A and 7.3 in Group B at Day 5(P=0.00). At days 10 and 14, both the groups had no statistically significant difference in pain score. The opioid requirement in group A was significantly less, the average being 636.67 mg and in Group B being 2123.34 mg. Conclusions: 5 % lidocaine patch was found to be useful for short period management of neuropathic pain along with allodynia derived from a painful scar. But its long term usefulness is yet to be validated.

 


Keywords : Keywords: Cancer Pain; Lidocaine; Nociceptors; Mastectomy; Neuralgia; Allodynia; Pain Assessment; Opioid
Corresponding Author : Nupur Moda